Evidence map›Paper›PMID 18491232›Full record

ArticleApoptosis : an international journal on programmed cell death2008

Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) induced mitochondrial pathway to apoptosis and caspase activation is potentiated by phospholipid scramblase-3.

Kenneth Ndebele, Philimon Gona, Tai-Guang Jin, Nordine Benhaga, Anas Chalah, Mauro Degli-Esposti, Roya Khosravi-Far

Open access · greenAbstract read
In one paragraph

Article in Apoptosis : an international journal on programmed cell death, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Nano-TRAIL: a promising path to cancer therapy.Cancer drug resistance (Alhambra, Calif.) · 2023
    Review
  16. Review
  17. Article
  18. Article
  19. Role of WWOX and NF-κB in lung cancer progression.Translational respiratory medicine · 2013
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Kenneth NdebeleDepartment of Pathology, Harvard Medical School, Beth Israel Deaconess Medical Center, 99 Brookline Ave, Boston, MA 02215, USA.
Philimon Gona
Tai-Guang Jin
Nordine Benhaga
Anas Chalah
Mauro Degli-Esposti
Roya Khosravi-Far
Beth Israel Deaconess Medical Center · USBoston University · USHadassah Medical Center · ILHarvard University · USUniversity of Manchester · GB

Funding

Training Program in Angiogenesis &InflammationT32HL007893 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI DVORAK, HAROLD FISHER · 1998 to 2017
$5.5M
Tumor Selective Apoptosis by TRAILR01HL080192 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI KHOSRAVI-FAR, ROYA · 2005 to 2010
$3.6M
Oncogene-Induced Evasion from ApoptosisR01CA105306 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI KHOSRAVI-FAR, ROYA · 2005 to 2009
$1.6M
NCI NIH HHS CA105306NCI NIH HHS R01 CA105306NHLBI NIH HHS 5 T32 HL07893NHLBI NIH HHS HL080192NHLBI NIH HHS R01 HL080192NHLBI NIH HHS T32 HL007893
6 · The paper itself

Abstract

Tumor Necrosis Factor (TNF)-Related Apoptosis-Inducing Ligand (TRAIL) initiate pathways of cell death in which caspase activation is mediated either directly (without mitochondrial amplification), or indirectly via the release of apoptogenic factors from mitochondria. Phospholipid scramblases (PLS) are enzymes that play a key role in cellular function by inducing bidirectional movement of membrane lipids. Changes in mitochondrial membrane lipids, cardiolipin, are critical for mediating apoptotic response in many cell-types. PLS3 is a phospholipid scramblase that is localized to mitochondria and is thought to be involved in the regulation of apoptotic signals. Here we report that exogenous-expression of PLS3 enhances apoptotic death induced by TRAIL. This is acheived by potentiating the mitochondrial arm of the death pathway. Thereby, PLS3 expression facilitates changes in mitochondrial membrane lipids that promote the release of apoptogenic factors and consequent full activation and processing of the caspase-9 and effector caspase-3. Moreover, we show that knock-down of endogenous PLS3 suppresses TRAIL-induced changes in cardiolipin. Finally, we demonstrate that TRAIL-induced activation of PKC-delta mediates regulation of the PLS3-induced changes in cardiolipin.

Indexed as

ApoptosisBase SequenceCardiolipinsCaspase 3Caspase 8CaspasesDNA PrimersEnzyme ActivationHumansJurkat CellsMembrane LipidsMitochondriaModels, BiologicalMutagenesis, Site-DirectedPhospholipid Transfer ProteinsProtein Kinase C-deltaCardiolipinsCASP3 protein, humanCASP8 protein, humanCaspase 3Caspase 8CaspasesDNA PrimersMembrane LipidsPhospholipid Transfer ProteinsPLSCR3 protein, humanProtein Kinase C-deltaRecombinant ProteinsRNA, Small InterferingTNF-Related Apoptosis-Inducing LigandTNFSF10 protein, human

Identifiers

PMID18491232
PMCPMC2941895
OpenAlexW2072831971

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.